BioCentury
ARTICLE | Company News

Apricus Biosciences management update

November 12, 2012 8:00 AM UTC

Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Transitioned: Steve Martin, SVP and CFO, to interim CEO; he replaces Bassam Damaj who resigned ...